Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.

Slides:

Advertisements

Similar presentations

Fig.1 Complexity of the surgeries according to BAS. Histogram.

Advertisements

Fig. 1. TGF results in different group

Table 1 Cause of death for arrested organ donors

Table 1 Patient characteristics

Fig. 1 Diagram of method C for bronchial closure

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma Hideyuki Imoto, MD, Toshihiro.

Fig. 1 Clinical model of coronary collateral flow

Table 1 Staging of resected tumours of the oesophagus

Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.

Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.

Table 1 Comparison of perioperative patient characteristics by groups

Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair.

Prognosis of younger patients in non-small cell lung cancer

Table 1 Hospital mortality

Figure 1: IPW-adjusted cumulative incidence function of cardiac death at 12 years, with non-cardiac death as competing risk. IPW: inverse probability of.

From: Long-term respiratory functional results after pneumonectomy

Table 2: Baseline characteristicsa of non-survivors and survivors and univariate logistic models predicting 30-day mortality From: The association.

Fig. 1 Protocol for oral sildenafil administration for persistent postoperative pulmonary hypertension in paediatric patients. Each dose was given via.

Table 1 Baseline patient characteristics

Table 1 Recipient’s characteristics.

Figure 3: Mean gradient according to valve size, 6 weeks after surgery

Fig. 3 Summary estimates of the relative risks for the different surgical techniques for late mortality. Comparing the two main techniques, EVR showed.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

PUBLISH ONLY Journal of Thoracic Oncology

Table 1 The 5 stages of constructing a BET

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Kaplan–Meier curves for a, b) progression-free survival (PFS) and c, d) overall survival (OS) in a, c) large-cell neuroendocrine carcinoma patients and.

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma Giulio Melloni, MD, Claudio.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

Operation and Chemotherapy: Prognostic Factors for Lung Cancer With One Synchronous Metastasis Anne-Claire Toffart, MD, PhD, Michaël Duruisseaux, MD,

Osteopontin-Expressing Macrophages in Non-Small Cell Lung Cancer Predict Survival Yue Li, MD, Bing-sheng Sun, MD, PhD, Baoxiang Pei, MD, Chen-guang Li,

Tumoral presence of human cytomegalovirus is associated with shorter disease-free survival in elderly patients with colorectal cancer and higher levels.

Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer Aritoshi Hattori, MD, Takeshi Matsunaga, MD, Kazuya.

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Surgical Treatment of Metachronous Second Primary Lung Cancer

Sleeve lung resection for lung cancer: Analysis according to the type of procedure Kazumichi Yamamoto, MD, Yoshihiro Miyamoto, MD, Akihiro Ohsumi, MD,

ERCC1 and BRAC1 mRNA Expression Levels in the Primary Tumor Could Predict the Effectiveness of the Second-Line Cisplatin-Based Chemotherapy in Pretreated.

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Ugo Pastorino, MD, Marc Buyse, ScD, Godehard Friedel, MD, Robert J

Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic.

Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu,

Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non- Small Cell Lung Cancer Adalet Demir, MD, Akif Turna, MD, PhD, FETCS,

PUBLISH ONLY Journal of Thoracic Oncology

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Extratumoral Vascular Invasion Is a Significant Prognostic Indicator and a Predicting Factor of Distant Metastasis in Non-small Cell Lung Cancer Yoshihisa.

Surgical Therapy for Bilateral Multiple Primary Lung Cancer

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung Marc Riquet, MD, Dominique Manac’h, MD, Françoise Le.

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy Haiyu Zhou, MD, Luis F. Tapias, MD, Henning A.

Relation between recurrence and expression of proliferating cell nuclear antigen, sialyl Lewis X, and sialyl Lewis a in lung cancer Jun-ichi Ogawa, MD,

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Prognostic Differences in Subgroups of Patients With Surgically Resected T3 Non-Small Cell Lung Cancer Jae Hyun Jeon, MD, Moon Soo Kim, MD, Duk Hwan.

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Carcinoma of the esophagus: Prognostic significance of histologic type

Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung Florian Eichhorn, MD, Hendrik Dienemann, MD,

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer Eun Young Kim, MD, Young Saing Kim, MD, Inkeun Park, MD,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer Steven M Keller, MD, Sudeshna Adak,

Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases Marc Riquet, MD, PhD, Patrick Bagan,

Kaplan–Meier analysis of PFS and OS in patients with advanced non-small cell lung cancer with adenocarcinoma histology with time since start of first-line.

Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma Joachim Pfannschmidt, MD, Hans Hoffmann, MD, PhD, Thomas.

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Razvan Diaconescu, MD, Chantal Lafond, MD, Renaud Whittom, MD

Prognostic Significance of Tumor Size in Patients with Stage III Non–Small-Cell Lung Cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey.

Presentation transcript:

Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were found in overall survival and disease-free survival according to the number of nodal stations involved (p = 0.80 and 0.38). Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4):491-497. doi:10.1016/j.ejcts.2010.02.033 Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

Fig. 2 Overall and disease-free survival according to the number of nodal zones involved. The overall survival and disease-free survival were significantly better in the single-zone metastasis group than in 2-zone group (p = 0.003 and p ≪ 0.001) and there were no survival difference between two-zone and three-zone metastasis group (p = 0.75 and 0.45). Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4):491-497. doi:10.1016/j.ejcts.2010.02.033 Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

Fig. 1 Overall and disease-free survival Fig. 1 Overall and disease-free survival. The overall 5-year survival rate was 36.5% (median, 39.3 months). Median disease-free survival was 17.4 months. Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4):491-497. doi:10.1016/j.ejcts.2010.02.033 Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

Table 3 Prevalence of nodal zones according to the primary tumor location of two-zone metastasis patients. Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4):491-497. doi:10.1016/j.ejcts.2010.02.033 Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

Table 2 Prevalence of nodal zones according to the primary tumour location of single-zone metastasis patients. Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4):491-497. doi:10.1016/j.ejcts.2010.02.033 Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

Table 1 Patient characteristics. Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4):491-497. doi:10.1016/j.ejcts.2010.02.033 Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

Table 4 Univariate analysis of prognostic factors for overall and disease-free survival. Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4):491-497. doi:10.1016/j.ejcts.2010.02.033 Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

Table 5 Multivariate analysis of prognostic factors for overall survival. Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆ Eur J Cardiothorac Surg. 2010;38(4):491-497. doi:10.1016/j.ejcts.2010.02.033 Eur J Cardiothorac Surg | © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery